Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum
NCT ID: NCT05137925
Last Updated: 2025-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
80 participants
INTERVENTIONAL
2023-09-01
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mindfulness Based Cognitive Therapy for Psychological Distress in Pregnancy
NCT02214732
Mindfulness Based Cognitive Therapy (MBCT) During Pregnancy
NCT03809572
Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders
NCT02150681
How Does Mindful Mood Balance for Moms Work?
NCT05000879
Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depressive Relapse/Recurrence
NCT02387424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mindfulness-Based Cognitive Therapy (MBCT)
MBCT will be delivered in a group based, videoconference format with 90 minute sessions 1x/week.
Mindfulness-Based Cognitive Therapy (MBCT)
MBCT is an 8-week group-based treatment modality designed specifically to prevent recurrence of depressive symptoms. MBCT combines principles of cognitive behavioral therapy and mindfulness meditation to help participants change the way in which they relate to automatic negative thinking patterns that trigger symptom recurrence. Through awareness and acceptance of negative thoughts and emotions, participants learn how to dismiss negative thoughts and to tolerate distress and uncertainty.
Treatment as Usual (TAU)
TAU, or the control group, provides information about the benefits of mindfulness in pregnancy, offers referrals for psychotherapy in the community, and involves monthly phone or videoconference calls to maintain engagement.
Treatment as Usual (TAU)
TAU (the control group) provides participants with information about the benefits of mindfulness in pregnancy and offers referrals for psychotherapy in the community. Participants in TAU are contacted monthly via phone or videoconference call to maintain engagement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindfulness-Based Cognitive Therapy (MBCT)
MBCT is an 8-week group-based treatment modality designed specifically to prevent recurrence of depressive symptoms. MBCT combines principles of cognitive behavioral therapy and mindfulness meditation to help participants change the way in which they relate to automatic negative thinking patterns that trigger symptom recurrence. Through awareness and acceptance of negative thoughts and emotions, participants learn how to dismiss negative thoughts and to tolerate distress and uncertainty.
Treatment as Usual (TAU)
TAU (the control group) provides participants with information about the benefits of mindfulness in pregnancy and offers referrals for psychotherapy in the community. Participants in TAU are contacted monthly via phone or videoconference call to maintain engagement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* reporting at least mild psychological distress (based on self-report)
* access to high-speed internet or cellular network access
* located in the U.S.
Exclusion Criteria
* symptom severity necessitating a higher level of clinical care
* current psychosis
* untreated mania
* active substance abuse
* lack of high-speed internet connection or cellular network access
* planning to be traveling without access to internet for more than two weeks in the next 12 months
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
American Psychological Foundation
OTHER
The Pittsburgh Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michele Levine
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michele Levine, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh Medical Center
Shannon Donofry, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh-Psychology and (primarily) AHN Psychiatry & Behavioral Health Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Western Psychiatric Institute & Clinic
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY21060191
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.